Which drugs does patent 6,429,210 protect, and when does it expire?
Patent 6,429,210 protects PLAVIX and is included in one NDA. There has been one Paragraph IV challenge on Plavix.
Protection for PLAVIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-two patent family members in forty-three countries.